Author

Sriram Chitta

The University of Texas MD Anderson Cancer CenterORCID 0000-0002-2979-9560Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1 Assay:multiome· 1 Organism:non-human primate· 1

Frequent Co-Authors

Dara P. DowlatshahiiD· 1 shared Hikaru SugimotoiD· 1 shared Janine HenseliD· 1 shared Jianli DaiiD· 1 shared Joe H. SimmonsiD· 1 shared Kaira A. ChurchiD· 1 shared Kathleen M. McAndrewsiD· 1 shared Kent A. Arian· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Dara P. DowlatshahiORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Development of an engineered extracellular vesicles-based vaccine platform for combined delivery of mRNA and protein to induce functional immunity

Xin Luo, Kathleen M. McAndrews, Kent A. Arian, Sami J. Morse, Viktoria Boeker, Shreyasee V. Kumbhar, Yingying Hu, Krishnan K. Mahadevan, Kaira A. Church, Sriram Chitta, Nicolas T. Ryujin, Janine Hensel, Jianli Dai, Dara P. Dowlatshahi, Hikaru Sugimoto, , Raghu Kalluri

This paper develops an engineered extracellular vesicles-based vaccine platform for combined mRNA and protein delivery, showing tumor regression and immune responses in preclinical models.

Journal of Controlled Release · Aug 30, 2024Peer-reviewedImmunology